Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics ; day:14 ; month:10 ; year:2024 ; extent:25
Angewandte Chemie / International edition. International edition ; (14.10.2024) (gesamt 25)
- Urheber
-
Desgagné, Michael
Chartier, Magali
Lagard, Camille
Ferková, Sára
Choquette, Mathieu
Longpré, Jean‐Michel
Côté, Jérôme
Boudreault, Pierre‐Luc
Sarret, Philippe
- DOI
-
10.1002/anie.202405941
- URN
-
urn:nbn:de:101:1-2410151415040.181639401512
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Desgagné, Michael
- Chartier, Magali
- Lagard, Camille
- Ferková, Sára
- Choquette, Mathieu
- Longpré, Jean‐Michel
- Côté, Jérôme
- Boudreault, Pierre‐Luc
- Sarret, Philippe
Ähnliche Objekte (12)
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics
Non-opioid (OTC) analgesics : risks/benefits in perspective
Nociceptin/orphanin FQ opioid peptide receptor-related ligands as potential analgesics in the endometriosis-associated pain
Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
Endomorphins: Promising Endogenous Opioid Peptides for the Development of Novel Analgesics
Differential interaction patterns of opioid analgesics with µ opioid receptors correlate with ligand-specific voltage sensitivity
Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Erratum to: Pain Management in Patients with Cancer: Focus on Opioid Analgesics
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Correction to: Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics
Non-opioid (OTC) analgesics : risks/benefits in perspective
Nociceptin/orphanin FQ opioid peptide receptor-related ligands as potential analgesics in the endometriosis-associated pain
Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
Endomorphins: Promising Endogenous Opioid Peptides for the Development of Novel Analgesics
Differential interaction patterns of opioid analgesics with µ opioid receptors correlate with ligand-specific voltage sensitivity
Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Erratum to: Pain Management in Patients with Cancer: Focus on Opioid Analgesics
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Correction to: Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics
Non-opioid (OTC) analgesics : risks/benefits in perspective
Nociceptin/orphanin FQ opioid peptide receptor-related ligands as potential analgesics in the endometriosis-associated pain
Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis
Endomorphins: Promising Endogenous Opioid Peptides for the Development of Novel Analgesics
Differential interaction patterns of opioid analgesics with µ opioid receptors correlate with ligand-specific voltage sensitivity
Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
Erratum to: Pain Management in Patients with Cancer: Focus on Opioid Analgesics
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan